Â鶹´«Ã½

Skip to main content

Refine your results

Filters

Displaying 1261 - 1280 of 1549

Press Release

Announced Actions for March 18, 2003

Date
The Commission has received a petition from Solvay S.A. (Solvay) to reopen and modify the Commission's hold separate order regarding Solvay's acquisition of Ausimont S.p.A. In its petition, which is...
Feb26
Event

Health Care and Competition Law and Policy Hearings

-
The Â鶹´«Ã½ Trade Commission and Department of Justice will commence public hearings in Washington, D.C. on February 26, 2003 on the implications of competition law and policy for health care...
Cases and Proceedings

Baxter International Inc., and Wyeth, In the Matter of

Baxter settled Commission concerns stemming from its $316 million proposed acquisition of Wyeth Corporation's generic injectable drug business and agreed to divest several pharmaceutical products. The Commission charged that the acquisition would reduce competition in the manufacture and sale of propofol (a general anesthetic); new injectable iron replacement therapies; metocloprarnide (used to treat nausea); and vecuronium and pancuronium (neuromuscular blocking agents used to temporarily freeze muscles during surgery). The consent order requires divestitures in each of the pharmaceutical markets.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0210171
Docket Number
C-4068
Press Release

Announced Action for January 29, 2003

Date
On January 29, 2003 the Commission filed an amicus brief in the U.S. District Court for the Eastern District of Pennsylvania regarding the pending patent litigation between SmithKline Beecham (now...
Nov19
Event

Workshop on Deception in Weight Loss Advertising

The FTC held a workshop to explore alternate approaches to reducing deceptive claims in advertising for weight-loss products. Following up on the issuance of the FTC staff report, Weight-Loss...

Displaying 1261 - 1280 of 1549

Return to top